Germany Expands mRNA Vaccine Production Capacity to Up to One Billion Doses Per Year to Supply the World in the Next Pandemic
Earlier this month, the biotech division of the German firm Wacker inaugurated a spanking new mRNA production facility in Halle, where, per the company, it will be able to manufacture up to 200 million doses of mRNA vaccines per year. The facility reportedly cost some €100 million to build.
But 200 million doses of mRNA vaccines for what?
To read the rest of this article, you need to donate at least £5/month or £50/year to the Daily Sceptic, then create an account on this website. The easiest way to create an account after you’ve made a donation is to click on any article, scroll to the bottom, then click on the box labelled ‘Sign Up’ on the right hand side, making sure you enter the same email address as the one you used when making your donation. Once you’re logged in, you can then read all our paywalled content, including this article. Being a donor will also entitle you to comment below the line, discuss articles with our contributors and editors in a members-only Discord forum and access the premium content in the Sceptic, our weekly podcast. A one-off donation of at least £5 will also entitle you to the same benefits for one month. You can donate here.
There are more details about how to create an account, and a number of things you can try if you’re already a donor – and have an account – but cannot access the above perks on our Premium page.
Read More: Germany Expands mRNA Vaccine Production Capacity to Up to One Billion Doses Per Year
